{"doc_key": "sents_context_OR_True", "dataset": "ace05", "sentences": [["Ultimately", ",", "the", "widespread", "use", "of", "portable", "sequencers", "for", "the", "purpose", "of", "EID", "surveillance", "will", "have", "consequences", "beyond", "those", "envisaged", "and", "promoted", "within", "the", "sequencing", "singularity", "vision", "and", "at", "scales", "occluded", "by", "its", "implicit", "geography", "."], ["Instead", ",", "we", "argue", "that", "the", "mechanism", "of", "suppression", "of", "ST-148-resistant", "virus", "in", "the", "mouse", "is", "the", "same", "as", "that", "observed", "in", "tissue", "culture", "."], ["The", "continued", "suppression", "of", "drug", "resistance", "over", "4", "days", "of", "infection", "could", "indicate", "that", "viral", "spread", "is", "local", ",", "such", "as", "might", "occur", "in", "the", "lymph", "nodes", "or", "spleen", "."], ["Therefore", ",", "abnormalities", "in", "serum", "concentrations", "of", "sHLA-I", "and", "sHLA-II", "are", "expected", "in", "MS", "patients", "."], ["Moreover", ",", "because", "the", "detectability", "of", "sHLA-I", "molecules", "in", "the", "CSF", "has", "been", "demonstrated", "25", ",", "it", "could", "be", "of", "interest", "to", "investigate", "the", "presence", "and", "the", "biologic", "behavior", "of", "sHLA-I", "and", "sHLA-II", "molecules", "in", "the", "CSF", "of", "MS", "patients", "."], ["However", ",", "to", "the", "best", "of", "our", "present", "knowledge", ",", "no", "information", "exists", "on", "the", "level", "of", "sHLA-I", "and", "sHLA-II", "in", "serum", "and", "CSF", "of", "MS", "patients", "."], ["However", ",", "isolated", "CSCs", "are", "used", "in", "most", "current", "studies", "that", "lacks", "a", "microenvironment.651", "Fourth", ",", "the", "environmental", "factors", "in", "CSC", "niches", "are", "not", "well", "understood", ",", "and", "the", "relationship", "between", "TAMsCAFs", "and", "CSCs", "has", "not", "been", "well", "studied.645"], ["Fifth", ",", "since", "CSCs", "also", "share", "some", "signaling", "pathways", "with", "normal", "stem", "cells", ",", "not", "all", "the", "regulatory", "factors", "that", "contribute", "to", "CSCs", "are", "appropriate", "for", "use", "as", "therapeutic", "targets", "in", "cancer", "treatment", "."], ["Sixth", ",", "whether", "CSCs", "should", "be", "activated", "or", "arrested", "is", "an", "open", "question", "in", "cancer", "therapy.652"], ["Seventh", ",", "novel", "signaling", "and", "more", "regulatory", "levels", ",", "such", "as", "RNA", "editing,653", "epigenetics,654", "and", "cellular", "metabolism,655", "should", "be", "considered", "in", "cancer", "therapy", "because", "they", "also", "contribute", "to", "the", "stemness", "of", "CSCs", "."], ["Eighth", ",", "some", "inhibitors", "that", "target", "CSC", "signaling", "are", "not", "very", "specific", ",", "and", "so", "new", "inhibitors", "need", "to", "be", "designed.656"], ["Ninth", ",", "natural", "products", "that", "target", "CSCs", "should", "also", "be", "studied", "in", "the", "future.657"], ["Finally", ",", "novel", "ways", "of", "targeting", "the", "microenvironment", "of", "CSCs", "are", "also", "promising", "and", "need", "to", "be", "explored", "."], ["The", "C.", "albicans", "ORFeomeV2", "is", "of", "unprecedented", "quality", ",", "as", "all", "ORFs", "in", "the", "collection", "are", "fully", "sequenced", ",", "which", "remains", "an", "exception", "in", "large-scale", "ORFeome", "projects", "where", "ORFs", "are", "rarely", "sequenced", "in", "their", "entirety", "and", "only", "the", "5-", "and", "3-ends", "of", "the", "cloned", "ORFs", "are", "sequenced", "to", "confirm", "identity", "and", "the", "absence", "of", "frameshift", "mutations", "in", "the", "primers", "16,17,19,22,24,30", "."], ["Nevertheless", ",", "it", "should", "be", "noted", "that", "further", "analysis", "of", "each", "mutation-containing", "ORF", "is", "required", "to", "determine", "whether", "or", "not", "mutations", "affect", "the", "function", "of", "the", "ORF", "."], ["Given", "these", "high", "standards", ",", "the", "success", "rate", "of", "83", "that", "we", "achieved", "with", "the", "C.", "albicans", "ORFeomeV2", "is", "quite", "remarkable", "."], ["Future", "work", "considering", "the", "implications", "of", "ubiquitous", "realtime", "sequencing", "for", "these", "geographies", "of", "folded", "life", "will", "expand", "our", "understanding", "of", "these", "relationships", "."], ["To", "this", "end", ",", "we", "used", "the", "MHV-3-induced", "mouse", "FH", "model", "to", "demonstrate", "that", "PD-1", "signaling", "acts", "to", "limit", "the", "immunopathological", "damage", "during", "disease", "progression", "."], ["Furthermore", ",", "our", "findings", "suggested", "that", "enhanced", "PD-1", "signaling", "might", "represent", "a", "useful", "immunotherapeutic", "strategy", "for", "treating", "FH", "."], ["The", "humectation", "of", "the", "stratum", "corneum", "induced", "by", "the", "glycerin", "27", "and", "the", "disruption", "of", "the", "lipid", "bilayer", "induced", "by", "the", "octyldodecyl", "lactate", "28", "were", "likely", "associated", "with", "the", "antigen", "permeation", "."], ["Unfortunately", ",", "although", "we", "planned", "to", "examine", "the", "antigen", "permeation", "of", "the", "stratum", "corneum", ",", "we", "were", "unable", "to", "obtain", "specific", "Raman", "spectra", "of", "TT", "or", "DT", "."], ["We", "speculated", "that", "the", "TCI", "formulation", "delivered", "antigens", "to", "the", "LCs", "by", "changing", "the", "skin", "properties", "without", "destroying", "the", "stratum", "corneum", "as", "a", "physical", "barrier", ",", "because", "the", "immune", "response", "was", "actually", "induced", "by", "application", "of", "the", "TCI", "formulation", "."], ["Furthermore", ",", "widespread", "microvascular", "thrombosis", "in", "patients", "with", "SARS", "infection", "involving", "kidneys", ",", "lungs", "and", "other", "organs", "were", "reported3,4"], ["Therefore", ",", "future", "research", "should", "investigate", "the", "molecular", "and", "cellular", "effects", "of", "SARS-CoV-2", "in", "vascular", "system", "and", "explore", "the", "selective", "roles", "of", "CD209L", "versus", "ACE2", "in", "the", "vascular", "system", "and", "explore", "therapeutic", "potential", "of", "CD209L", "against", "COVID-19", "."], ["Aguirre", "finds", "that", "despite", "needed", "concerted", "global", "effort", ",", "only", "25", "of", "countries", "have", "implemented", "a", "national", "policy", "to", "address", "antibiotic", "resistance", "39", "."], ["It", "is", "not", "surprising", "that", "low-income", "countries", "might", "find", "it", "difficult", "to", "identify", "resources", "to", "develop", "and", "implement", "an", "intersectoral", "AMR", "action", "plan", "."], ["But", "middle-", "and", "high-income", "countries", "are", "falling", "behind", "as", "well", "only", "23", "European", "countries", "had", "approved", "an", "adequate", "action", "plan", "by", "2017", "11", "."], ["Conversely", ",", "the", "DTI", "RD", "component", "can", "be", "driven", "by", "myelin", "changes", "61", "."], ["Our", "data", "suggest", "that", "the", "reduced", "DTI", "RD", "after", "iNSC", "transplantation", "Fig.", "4h", "may", "possibly", "be", "influenced", "by", "changes", "in", "reactive", "astrogliosis", "after", "chronic", "CPZ", ",", "since", "GFAP", "and", "MOG", "immunoreactivity", "exhibited", "similar", "coherence", "Fig.", "6f-g", "."], ["However", ",", "our", "2-dimensional", "pixel", "scale", "structure", "tensor", "analysis", "can", "reveal", "local", "microstructure", "features", "but", "can", "not", "demonstrate", "specific", "correlation", "to", "the", "much", "larger", "3-dimensional", "DTI", "voxel", "scale", "features", "."], ["COVID-19", "is", "an", "infectious", "disease", "that", "has", "quickly", "spread", "worldwide", ",", "causing", "a", "pandemic", "."], ["The", "main", "clinical", "manifestation", "is", "pneumonia", "."], ["To", "prevent", "this", ",", "we", "decided", "to", "add", "some", "level", "of", "transparency", "to", "the", "interaction", "for", "the", "future", "experiment", "by", "making", "the", "robot", "ask", "for", "feedback", "after", "every", "move", ",", "and", "in", "response", "to", "a", "negative", "feedback", "convey", "its", "egocentric", "perspective", "e.g.", "but", "I", "moved", "them", "to", "my", "leftright", "."], ["Using", "the", "takeaways", "from", "the", "pilot", "in", "our", "next", "study", "we", "plan", "to", "explore", "how", "childrens", "choice", "of", "perspective", "is", "affected", "by", "the", "robotics", "choice", "of", "perspective", "."], ["Spiroheterocyclics", "play", "a", "vital", "role", "in", "biological", ",", "medicinal", ",", "and", "materials", "sciences2,3", "and", "in", "the", "synthesis", "of", "many", "quinoxalines", "."], ["Thus", ",", "much", "attention", "has", "been", "paid", "to", "the", "study", "of", "spiroheterocyclics", "due", "to", "their", "unique", "spirostructures", "with", "wider", "biological", "and", "other", "activities", "to", "explore", "their", "photocatalytic", "PC", "potential", "."], ["Huang", "et", "al.4", "synthesized", "pharmacological", "agents", ",", "but", "synthesizing", "spiroheterocyclics", "with", "a", "minimum", "number", "of", "steps", "in", "a", "shorter", "time", "using", "green", "chemistry", "has", "been", "a", "major", "challenge", "."], ["These", "materials", "would", "be", ",", "in", "this", "regard", ",", "a", "great", "promise", "as", "an", "exceptional", "candidate", "for", "constructing", "bioprotective", "equipment", "."], ["Despite", "their", "outstanding", "potential", ",", "the", "major", "problem", "associated", "with", "the", "photoantimicrobial", "materials", "is", "their", "solely", "photo-driven", "biocidal", "character", ",", "with", "the", "instantaneous", "biocidal", "function", "fast", "decaying", "or", "quenching", "under", "dim", "light", "and", "dark", "conditions", "26", ",", "27", "."], ["Moreover", ",", "most", "of", "these", "products", "were", "driven", "by", "high-energy", "ultraviolet", "UV", "light", "rather", "than", "the", "readily", "available", "daylight", "source", "28", ",", "29", ",", "which", "are", "often", "energetically", "and", "operationally", "intensive", ",", "focused", "on", "specialized", "UV", "irradiation", "systems", ",", "thus", "significantly", "limiting", "the", "usability", "for", "bioprotection", "."]], "predicted_ner": [[], [[38, 38, "PER", 6.8422, 0.9854]], [], [[105, 105, "PER", 15.4937, 1.0]], [[146, 146, "PER", 7.005, 0.9987]], [[154, 154, "GPE", 4.7801, 0.5831], [174, 174, "PER", 10.8728, 1.0]], [], [[218, 218, "ORG", 1.2146, 0.5382]], [], [], [[301, 301, "ORG", 3.3023, 0.8432], [302, 302, "ORG", 5.8652, 0.9634]], [], [], [[353, 354, "ORG", 9.9626, 0.9999]], [], [[452, 452, "ORG", 4.9294, 0.9121], [456, 457, "ORG", 10.1515, 0.9999]], [[480, 480, "PER", 12.4531, 1.0]], [[490, 490, "PER", 6.4236, 0.9815]], [[514, 514, "PER", 10.3251, 0.986]], [], [[566, 566, "ORG", 6.0586, 0.9707], [578, 578, "ORG", 5.1872, 0.8166], [587, 587, "ORG", 2.5763, 0.8292]], [[591, 591, "PER", 6.7899, 0.9951]], [[637, 637, "PER", 20.4879, 1.0]], [], [[688, 688, "PER", 2.6322, 0.9277], [698, 698, "GPE", 6.8826, 0.9988], [700, 700, "GPE", 20.8352, 1.0]], [[718, 718, "GPE", 28.4523, 1.0]], [[740, 740, "GPE", 25.4689, 1.0], [748, 748, "GPE", 14.9051, 1.0], [749, 749, "GPE", 24.7922, 1.0]], [], [[774, 774, "PER", 5.7952, 0.8216]], [[813, 813, "PER", 11.9735, 0.9976]], [], [], [[867, 867, "PER", 3.6632, 0.8606], [885, 885, "VEH", 1.0784, 0.7452], [906, 906, "PER", 14.7038, 1.0]], [[918, 918, "PER", 10.6607, 1.0], [920, 920, "PER", 7.1276, 0.8098], [923, 923, "ORG", 6.4332, 0.9097]], [], [[976, 976, "LOC", 0.158, 0.5151], [987, 987, "LOC", 0.8493, 0.6859]], [[993, 993, "ORG", 3.6122, 0.9737], [993, 994, "ORG", 1.6081, 0.8331]], [], [[1043, 1043, "PER", 8.2291, 0.9986]], []], "predicted_relations": [[], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [[749, 749, 748, 748, "PART-WHOLE", 9.6829, 0.9999]], [], [], [], [], [], [], [], [], [], [], [], [], []]}
